The global In-Silico Drug Discovery market size was valued at US$ 2313 million in 2024 and is forecast to a readjusted size of USD 4953 million by 2031 with a CAGR of 11.6% during review period.
In silico also known as computer-aided drug design is a process by which the drug is design or discovered by using computational methods. Drug discovery process is carried out to identify new drug molecules that can attach to a specific target. This method of identifying drugs is based on computation and the entire process is considered linear and consecutive. Various factors make in-silico drug discovery method more productive and a wise approach in comparison to earlier drug discovery methods used for the drug development process. In-silico drug design can play a significant role in all stages of drug development 鈥� from the initial lead designing to final stage clinical development.
The main In-Silico Drug Discovery players include Charles River, Certara USA, Inc., Evotec, etc. The top three In-Silico Drug Discovery players account for approximately 36% of the total global market. In terms of type, Consultancy as a Service is the largest segment, with a share about 41%. And in terms of Application, the largest application is Contract Research Organization, followed by Pharmaceutical Industry.
This report is a detailed and comprehensive analysis for global In-Silico Drug Discovery market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global In-Silico Drug Discovery market size and forecasts, in consumption value ($ Million), 2020-2031
Global In-Silico Drug Discovery market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global In-Silico Drug Discovery market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global In-Silico Drug Discovery market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for In-Silico Drug Discovery
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global In-Silico Drug Discovery market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River, Certara USA, Inc., Evotec, Dassault System (Biovia), Albany Molecular Research Inc. (AMRI), Selvita, Schr枚dinger, Inc., GVK BIO, OpenEye Scientific Software, Chemical Computing Group (CCG), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
In-Silico Drug Discovery market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Software as a Service (Cloud)
Consultancy as a Service
Software
Market segment by Application
Contract Research Organization
Pharmaceutical Industry
Academic and Research Institutes
Others
Market segment by players, this report covers
Charles River
Certara USA, Inc.
Evotec
Dassault System (Biovia)
Albany Molecular Research Inc. (AMRI)
Selvita
Schr枚dinger, Inc.
GVK BIO
OpenEye Scientific Software
Chemical Computing Group (CCG)
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe In-Silico Drug Discovery product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of In-Silico Drug Discovery, with revenue, gross margin, and global market share of In-Silico Drug Discovery from 2020 to 2025.
Chapter 3, the In-Silico Drug Discovery competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and In-Silico Drug Discovery market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of In-Silico Drug Discovery.
Chapter 13, to describe In-Silico Drug Discovery research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of In-Silico Drug Discovery by Type
1.3.1 Overview: Global In-Silico Drug Discovery Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global In-Silico Drug Discovery Consumption Value Market Share by Type in 2024
1.3.3 Software as a Service (Cloud)
1.3.4 Consultancy as a Service
1.3.5 Software
1.4 Global In-Silico Drug Discovery Market by Application
1.4.1 Overview: Global In-Silico Drug Discovery Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Contract Research Organization
1.4.3 Pharmaceutical Industry
1.4.4 Academic and Research Institutes
1.4.5 Others
1.5 Global In-Silico Drug Discovery Market Size & Forecast
1.6 Global In-Silico Drug Discovery Market Size and Forecast by Region
1.6.1 Global In-Silico Drug Discovery Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global In-Silico Drug Discovery Market Size by Region, (2020-2031)
1.6.3 North America In-Silico Drug Discovery Market Size and Prospect (2020-2031)
1.6.4 Europe In-Silico Drug Discovery Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific In-Silico Drug Discovery Market Size and Prospect (2020-2031)
1.6.6 South America In-Silico Drug Discovery Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa In-Silico Drug Discovery Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 Charles River
2.1.1 Charles River Details
2.1.2 Charles River Major Business
2.1.3 Charles River In-Silico Drug Discovery Product and Solutions
2.1.4 Charles River In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Charles River Recent Developments and Future Plans
2.2 Certara USA, Inc.
2.2.1 Certara USA, Inc. Details
2.2.2 Certara USA, Inc. Major Business
2.2.3 Certara USA, Inc. In-Silico Drug Discovery Product and Solutions
2.2.4 Certara USA, Inc. In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Certara USA, Inc. Recent Developments and Future Plans
2.3 Evotec
2.3.1 Evotec Details
2.3.2 Evotec Major Business
2.3.3 Evotec In-Silico Drug Discovery Product and Solutions
2.3.4 Evotec In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Evotec Recent Developments and Future Plans
2.4 Dassault System (Biovia)
2.4.1 Dassault System (Biovia) Details
2.4.2 Dassault System (Biovia) Major Business
2.4.3 Dassault System (Biovia) In-Silico Drug Discovery Product and Solutions
2.4.4 Dassault System (Biovia) In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Dassault System (Biovia) Recent Developments and Future Plans
2.5 Albany Molecular Research Inc. (AMRI)
2.5.1 Albany Molecular Research Inc. (AMRI) Details
2.5.2 Albany Molecular Research Inc. (AMRI) Major Business
2.5.3 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Product and Solutions
2.5.4 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Albany Molecular Research Inc. (AMRI) Recent Developments and Future Plans
2.6 Selvita
2.6.1 Selvita Details
2.6.2 Selvita Major Business
2.6.3 Selvita In-Silico Drug Discovery Product and Solutions
2.6.4 Selvita In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Selvita Recent Developments and Future Plans
2.7 Schr枚dinger, Inc.
2.7.1 Schr枚dinger, Inc. Details
2.7.2 Schr枚dinger, Inc. Major Business
2.7.3 Schr枚dinger, Inc. In-Silico Drug Discovery Product and Solutions
2.7.4 Schr枚dinger, Inc. In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Schr枚dinger, Inc. Recent Developments and Future Plans
2.8 GVK BIO
2.8.1 GVK BIO Details
2.8.2 GVK BIO Major Business
2.8.3 GVK BIO In-Silico Drug Discovery Product and Solutions
2.8.4 GVK BIO In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 GVK BIO Recent Developments and Future Plans
2.9 OpenEye Scientific Software
2.9.1 OpenEye Scientific Software Details
2.9.2 OpenEye Scientific Software Major Business
2.9.3 OpenEye Scientific Software In-Silico Drug Discovery Product and Solutions
2.9.4 OpenEye Scientific Software In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 OpenEye Scientific Software Recent Developments and Future Plans
2.10 Chemical Computing Group (CCG)
2.10.1 Chemical Computing Group (CCG) Details
2.10.2 Chemical Computing Group (CCG) Major Business
2.10.3 Chemical Computing Group (CCG) In-Silico Drug Discovery Product and Solutions
2.10.4 Chemical Computing Group (CCG) In-Silico Drug Discovery Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Chemical Computing Group (CCG) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global In-Silico Drug Discovery Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of In-Silico Drug Discovery by Company Revenue
3.2.2 Top 3 In-Silico Drug Discovery Players Market Share in 2024
3.2.3 Top 6 In-Silico Drug Discovery Players Market Share in 2024
3.3 In-Silico Drug Discovery Market: Overall Company Footprint Analysis
3.3.1 In-Silico Drug Discovery Market: Region Footprint
3.3.2 In-Silico Drug Discovery Market: Company Product Type Footprint
3.3.3 In-Silico Drug Discovery Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global In-Silico Drug Discovery Consumption Value and Market Share by Type (2020-2025)
4.2 Global In-Silico Drug Discovery Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global In-Silico Drug Discovery Consumption Value Market Share by Application (2020-2025)
5.2 Global In-Silico Drug Discovery Market Forecast by Application (2026-2031)
6 North America
6.1 North America In-Silico Drug Discovery Consumption Value by Type (2020-2031)
6.2 North America In-Silico Drug Discovery Market Size by Application (2020-2031)
6.3 North America In-Silico Drug Discovery Market Size by Country
6.3.1 North America In-Silico Drug Discovery Consumption Value by Country (2020-2031)
6.3.2 United States In-Silico Drug Discovery Market Size and Forecast (2020-2031)
6.3.3 Canada In-Silico Drug Discovery Market Size and Forecast (2020-2031)
6.3.4 Mexico In-Silico Drug Discovery Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe In-Silico Drug Discovery Consumption Value by Type (2020-2031)
7.2 Europe In-Silico Drug Discovery Consumption Value by Application (2020-2031)
7.3 Europe In-Silico Drug Discovery Market Size by Country
7.3.1 Europe In-Silico Drug Discovery Consumption Value by Country (2020-2031)
7.3.2 Germany In-Silico Drug Discovery Market Size and Forecast (2020-2031)
7.3.3 France In-Silico Drug Discovery Market Size and Forecast (2020-2031)
7.3.4 United Kingdom In-Silico Drug Discovery Market Size and Forecast (2020-2031)
7.3.5 Russia In-Silico Drug Discovery Market Size and Forecast (2020-2031)
7.3.6 Italy In-Silico Drug Discovery Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific In-Silico Drug Discovery Consumption Value by Type (2020-2031)
8.2 Asia-Pacific In-Silico Drug Discovery Consumption Value by Application (2020-2031)
8.3 Asia-Pacific In-Silico Drug Discovery Market Size by Region
8.3.1 Asia-Pacific In-Silico Drug Discovery Consumption Value by Region (2020-2031)
8.3.2 China In-Silico Drug Discovery Market Size and Forecast (2020-2031)
8.3.3 Japan In-Silico Drug Discovery Market Size and Forecast (2020-2031)
8.3.4 South Korea In-Silico Drug Discovery Market Size and Forecast (2020-2031)
8.3.5 India In-Silico Drug Discovery Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia In-Silico Drug Discovery Market Size and Forecast (2020-2031)
8.3.7 Australia In-Silico Drug Discovery Market Size and Forecast (2020-2031)
9 South America
9.1 South America In-Silico Drug Discovery Consumption Value by Type (2020-2031)
9.2 South America In-Silico Drug Discovery Consumption Value by Application (2020-2031)
9.3 South America In-Silico Drug Discovery Market Size by Country
9.3.1 South America In-Silico Drug Discovery Consumption Value by Country (2020-2031)
9.3.2 Brazil In-Silico Drug Discovery Market Size and Forecast (2020-2031)
9.3.3 Argentina In-Silico Drug Discovery Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa In-Silico Drug Discovery Consumption Value by Type (2020-2031)
10.2 Middle East & Africa In-Silico Drug Discovery Consumption Value by Application (2020-2031)
10.3 Middle East & Africa In-Silico Drug Discovery Market Size by Country
10.3.1 Middle East & Africa In-Silico Drug Discovery Consumption Value by Country (2020-2031)
10.3.2 Turkey In-Silico Drug Discovery Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia In-Silico Drug Discovery Market Size and Forecast (2020-2031)
10.3.4 UAE In-Silico Drug Discovery Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 In-Silico Drug Discovery Market Drivers
11.2 In-Silico Drug Discovery Market Restraints
11.3 In-Silico Drug Discovery Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 In-Silico Drug Discovery Industry Chain
12.2 In-Silico Drug Discovery Upstream Analysis
12.3 In-Silico Drug Discovery Midstream Analysis
12.4 In-Silico Drug Discovery Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Charles River
Certara USA, Inc.
Evotec
Dassault System (Biovia)
Albany Molecular Research Inc. (AMRI)
Selvita
Schr枚dinger, Inc.
GVK BIO
OpenEye Scientific Software
Chemical Computing Group (CCG)
听
听
*If Applicable.
